SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as investors highlight its role as critical decentralized infrastructure, particularly following its integration into major DeFi ecosystems and its partnership with the U.S. Department of Commerce to provide on-chain macroeconomic data. Community discussions emphasize the project's institutional backing, revenue-sharing model through token buybacks, and its increasing relevance as a key player in the Real World Asset (RWA) sector.

Vanguard Scottsdale Funds - Vanguard Short-Term Treasury ETF

Vanguard Short-Term Treasury ETF

Investors are increasingly turning to Vanguard Short-Term Treasury ETF as a defensive tool to navigate rising interest rates and yield curve volatility. The community is actively debating the merits of short-duration bond exposure compared to other fixed-income alternatives, highlighting the ETF's role in capital preservation during periods of market instability.

WisdomTree Trust - WisdomTree Floating Rate Treasury Fund

Investors are increasingly viewing floating rate treasury funds as an attractive, stable vehicle for parking cash and managing interest rate risk in a volatile market environment. The community highlights the fund's liquidity and consistent income potential, frequently comparing its performance and yield benefits against other short-duration bond ETFs.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is currently gaining strong community momentum, driven by anticipation for the upcoming 4/20 date and ongoing grassroots discussions surrounding global cannabis legalization and infrastructure. Investors and community members are actively sharing educational content on the endocannabinoid system and cannabis health research while highlighting the project's long-term focus on culture and decentralization.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is generating investor excitement following the commencement of commercial shipments of its FDA-approved TA-TMA treatment, Yartemlea, while the community closely monitors potential European regulatory developments and additional milestone payments from the Novo Nordisk partnership. Investors are actively debating the timing of a meaningful revenue ramp and potential buyout scenarios, with many expressing confidence in the drug's long-term value despite recent stock price volatility.

VICI Properties, Inc. is a real estate investment trust, which owns, acquires and develops gaming, hospitality and entertainment properties. It operates through the following segments: Real Property Business and Golf Course Business. The Real Property Business segment consists of leased real property. The Golf Course Business segment consists of four golf courses. The company was founded on July 5, 2016 and is headquartered in New York, NY.

VICI Properties Inc

VICI Properties is trending as investors weigh its role as a high-yield REIT against broader macro concerns, with the community actively debating whether current levels represent a deep-value buying opportunity or a yield trap. Discussion remains centered on the durability of its Las Vegas real estate portfolio and its reliable quarterly dividend payouts, even as market volatility creates friction with technical price trends.

LayerZero

LayerZero ($ZRO) is trending as the community highlights its critical role in cross-chain interoperability, specifically through its integration with the meme coin $CAW. Investors are actively discussing the protocol's burn-and-mint capabilities and its growing adoption across multiple chains, fueling bullish sentiment around its long-term infrastructure potential.

The Williams Cos., Inc. operates as an energy infrastructure company, which explores, produces, transports, sells and processes natural gas and petroleum products. It operates through the following segments: Transmission and Gulf of Mexico, Northeast G&P, and West. The Transmission and Gulf of Mexico segment consists of interstate natural gas pipelines, the Transco and Northwest Pipelines, as well as natural gas gathering and processing and crude oil production handling and transportation assets in the Gulf Coast region. The Northeast G&P segment includes midstream gathering, processing, and fractionation businesses in the Marcellus Shale region primarily in Pennsylvania and New York, and the Utica Shale region of eastern Ohio. The West segment consists of gas gathering, processing, and treating operations in the Rocky Mountain region of Colorado and Wyoming, the Barnett Shale region of north-central Texas, the Eagle Ford Shale region of south Texas, the Haynesville Shale region of northwest Louisiana, and the Mid-Continent region which includes the Anadarko, Arkoma, and Permian basins. The company was founded by David Williams and Miller Williams in 1908 and is headquartered in Tulsa, OK.

Williams Cos Inc

Williams Companies is attracting attention as surging power demand from AI-driven data centers positions its natural gas infrastructure as a critical energy solution. Investors are closely monitoring its long-term growth potential and pipeline stability while navigating recent regulatory milestones and broader energy sector volatility.

The Kroger Co. engages in the retail grocery business with added convenience to retail pharmacies and fuel centers. Its main focus is on growing households and increasing customer loyalty by delivering great value and convenience, and investing in four strategic pillars: Fresh, Brands, Data & Personalization and Seamless. Its brands include Big K, Smart Way, Heritage Farm, Simple Truth, and Simple Truth Organic. The company was founded by Barney Kroger in 1883 and is headquartered in Cincinnati, OH.

Kroger Co.

Kroger is trending following a positive earnings beat where stronger-than-expected e-commerce growth and pharmacy performance helped the stock maintain momentum. Investors are actively debating the company's ability to navigate current consumer spending shifts, with many focused on leadership transitions and potential impacts of ongoing merger litigation.

Midnight is a privacy-first blockchain that blends public verifiability with confidential data handling. You can use Midnight's selective disclosure and ZK proofs to build apps.

Midnight

NIGHT is experiencing significant volatility and intense community debate as traders navigate airdrop distribution schedules, listing news, and ongoing skepticism regarding its decentralization and relationship with Google Cloud. Investors are closely monitoring key support levels while vocal factions clash over the project's long-term utility versus its high market cap and leadership ties to the Cardano ecosystem.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going On With Shares Of SeaStar Medical Today?

Shares of SeaStar Medical Holding Corporation (NASDAQ: ICU) are trading lower Friday after the company initiated a reverse stock split.read more...

A Glimpse of SeaStar Medical Holding's Earnings Potential

SeaStar Medical Holding Corp. shares rose 7% to their highest level in more than three months on Wednesday after the company said an independent safety board had reviewed early data and recommended continuing its pivotal trial of a kidney failure therapy.However, the stock&nbsp;crashed 46% in after-hours trading on Wednesday.The Data Safety Monitoring Board (DSMB) conducted an interim review of the first 100 patients in the Neutralize-AKI study of the company’s Selective Cytopheretic Device (SCD) in adults with acute kidney injury requiring continuous renal replacement therapy.&nbsp;The panel found no device-related safety concerns and reported zero adverse events tied to the treatment. It also flagged a signal of potential clinical benefit across key measures.To boost the statistical power of the trial, the DSMB recommended increasing enrollment from 200 to 339 patients. SeaStar said 137 patients have already been enrolled and expects to complete recruitment near the end of 2026. The company plans to accelerate enrollment by adding new trial sites.The Neutralize-AKI trial will measure a composite of 90-day mortality or dialysis dependency, with additional endpoints including 28-day mortality, ICU-free days, and dialysis dependency at one year. Subgroup analyses will evaluate patients with sepsis and acute respiratory distress syndrome.SeaStar’s SCD therapy, marketed as Quelimmune, is already approved by the FDA for life-threatening acute kidney injury in children with sepsis or septic conditions. Early real-world registry data showed no safety concerns and a 75% survival rate at 28 days, suggesting a possible reduction in mortality compared with historical outcomes.On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.One user suggested that warrant holders had timed the news to capitalize on the stock’s spike, noting they could profit as long as shares remained above their average price and questioning whether the market could absorb the additional supply.<stembedurl>https://stocktwits.com/alphaonetrading/message/629922155</stembedurl>Another user said the recent price surge was only the beginning, arguing that strong safety signals from the trial support future runs and calling any near-term pullback a buying opportunity for the long term.<stembedurl>https://stocktwits.com/MasheredTrader/message/629918153</stembedurl><a href="https://stocktwits.com/symbol/ICU">SeaStar Medical’s stock</a> has declined 36.1% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Chronic kidney disease, computer illustration and light micrograph. The illustration shows the gross anatomy of kidneys with chronic glomerulonephritis. | Image source: Getty Images

SeaStar Medical Stock Jumps On Safety Board Backing For Kidney Trial; Retail Eyes Another Run Despite After-Hours Plunge

SeaStar’s SCD therapy, marketed as Quelimmune, is already approved by the FDA for life-threatening acute kidney injury in children with sepsis or septic conditions.

Equity

The trial’s enrollment target has been raised to 339 patients, with completion expected by late 2026.

Shares of SeaStar Medical Holding Corporation (ICU) slumped 61% on Friday afternoon after the healthcare company <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.seastarmedical.com/news/news-details/2025/SeaStar-Medical-Announces-Pricing-of-Up-to-8-Million-Public-Offering/default.aspx">announced</a> the pricing of a public offering of over six million shares of its common stock at $0.65.The offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday.The gross proceeds to the company from the offering are expected to be approximately $4 million, before deducting the placement agent’s fees and other offering expenses payable. SeaStar said it intends to use the net proceeds from the offering for general corporate purposes. The offering is expected to close on or about June 23, 2025.SeaStar Medical is a commercial-stage healthcare company focused on treatments for critically ill patients facing organ failure and potential loss of life.Its Quelimmune product was approved by the U.S. Food and Drug Administration (FDA) last year for the ultra-rare condition of life-threatening acute kidney injury (AKI) due to sepsis or a septic condition in critically ill pediatric patients.On Stocktwits, retail sentiment around SeaStar rose from ‘neutral’ to ‘bullish’ over the past 24 hours while message volume remained ‘high’.<figure class="image"><img style="aspect-ratio:622/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_20_at_1_11_54_PM_png_87eaa0be26.webp" alt="ICU's Sentiment Meter and Message Volume as of 1:10 p.m. ET on June 20, 2025 | Source: Stocktwits" width="622" height="64"><figcaption>ICU's Sentiment Meter and Message Volume as of 1:10 p.m. ET on June 20, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed dissatisfaction with the lack of clarity around the management’s decisions.<stembedurl>https://stocktwits.com/Saxon_stock/message/618487152</stembedurl>Another opined that the company is inching close to bankruptcy.<stembedurl>https://stocktwits.com/Cowsheeptheone/message/618483251</stembedurl><a href="https://stocktwits.com/symbol/ICU">ICU stock</a> is down by 81% this year and by over 93% in the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/amazon-ends-kia-soul-same-day-delivery-program/chlxYXvRRPx">Amazon Ends Same-Day Deliveries Via Kia Souls, Leans On Its Network Of Gig Workers: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

SeaStar Medical Stock Tanks At Discounted Pricing Of Public Offering, Retail Believes Company Is Inching Closer To Bankruptcy

The public offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday.

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company was founded on June 6, 2007 and is headquartered in Denver, CO.

ICU
SeaStar Medical Holding Corp

Feed

News

Sentiment

Fundamentals

Info

Latest ICU News

ICUSeaStar Medical Holding Corp